SNYR:NSD-Synergy CHC Corp. Common Stock (USD)

COMMON STOCK | Medical Distribution |

Last Closing

USD 4.2033

Change

+0.35 (+9.15)%

Market Cap

N/A

Volume

0.05M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-29 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
HSIC Henry Schein Inc

+3.77 (+4.95%)

USD 8.61B
PDCO Patterson Companies Inc

-0.03 (-0.10%)

USD 2.72B
AHG Akso Health Group ADR

+0.09 (+7.56%)

USD 0.35B
EDAP EDAP TMS SA

-0.01 (-0.44%)

USD 0.08B
YI 111 Inc

+0.02 (+0.36%)

USD 0.05B
COSM Cosmos Health Inc.

+0.03 (+3.71%)

N/A
ZYXI Zynex Inc

+0.23 (+2.86%)

N/A

ETFs Containing SNYR

MVA:AU VanEck Vectors Australian.. 7.66 % 0.00 %

+0.01 (+1.12%)

USD 0.59B
SLF:AU SPDR S&P/ASX 200 Listed P.. 4.27 % 0.00 %

+0.49 (+1.12%)

USD 0.56B
VAP:AU Vanguard Australian Prope.. 4.13 % 0.00 %

+0.25 (+1.12%)

USD 2.97B
SMLL:AU BetaShares Australian Sma.. 3.15 % 0.00 %

+0.06 (+1.12%)

N/A
VSO:AU Vanguard MSCI Australian .. 1.64 % 0.00 %

+0.77 (+1.12%)

USD 0.95B
1555:TSE Nikko Australia REIT 0.00 % 0.00 %

N/A

USD 15.35B

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.47% 38% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.47% 38% F 29% F
Trailing 12 Months  
Capital Gain 41,933.00% 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 41,933.00% 100% F 100% F
Trailing 5 Years  
Capital Gain 5,904.71% 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5,904.71% 100% F 100% F
Average Annual (5 Year Horizon)  
Capital Gain 1,799.15% 100% F 98% N/A
Dividend Return 1,799.15% 100% F 98% N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8,418.10% 14% F 2% F
Risk Adjusted Return 21.37% 71% C- 54% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.